Searched for
LAURUS PROFIT
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore....
- Stocks in news: HUL, Bajaj Finance, Adani Power, Adani Enterprises, Vedanta, Tata Motors PVIndian markets anticipate the US Fed's decision and election exit polls today. Key companies including HUL, Bajaj Finance, and Adani Power ...
- Laurus Labs Q4 Results: Profit soars 3-fold to Rs 234 crore; revenue at Rs 1,440 croreDrug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong...
- Buy Laurus Labs, target price Rs 480: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 23412.68 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 675: ICICI DirectLaurus Labs Ltd. key Products/Revenue Segments include Pharmaceutical Products, Traded Goods, Contract Service, Other Operating Revenue, Sc...
- Buy Laurus Labs, target price Rs 691: Jefferies GroupFor the quarter ended 31-03-2022, the company has reported a Consolidated Total Income of Rs 1426.12 Crore, up 37.91 % from last quarter To...
- Buy Laurus Labs, target price Rs 590: Edelweiss SecuritiesLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 29552.08 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 670: ICICI DirectLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 28077.03 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 580: Anand RathiLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27017.93 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 670: ICICI DirectLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27635.02 Crore) operating in Pharmaceutica...
- Laurus Labs Q4 results: Net profit zooms nearly 3-fold to Rs 297 crConsolidated revenue from operations of the company stood at Rs 1,411.93 crore for the quarter under consideration. It was Rs 839.14 crore ...
- Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 crThe company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to ...
- Laurus Labs Q2 results: Net profit jumps over four-fold to Rs 242.27 crConsolidated revenue from operations of the company stood at Rs 1,138.84 crore for the quarter under consideration. It was Rs 712.42 crore ...
- Lauras Labs’ Q2 net up 1% on higher capexFor the quarter ended September 2017, the company posted a 4.3% growth in its revenues to Rs 538.6 crore as against Rs 516.5 crore in the c...
- Laurus Labs hopes better profits in Q4 with lower interest outgo after debt retirementThe company repaid long term loans of Rs 226.3 crore from the proceeds of Rs 1,332 crore raised through an initial public offering (IPO) in...
Load More
